IDXX Trading Analysis - 11/19/2026 10:32 AM — TRU-SENTIMENT

IDXX (Idexx Laboratories Inc) at $689.82. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $12,720 vs put $0. RSI 72.0.

TRU-SENTIMENT · DeltaNeutral

IDXX Trading Analysis - 11/19/2026 10:32 AM — TRU-SENTIMENT

Options chain · Stock chart · Baseline chart

IDXX (Idexx Laboratories Inc) at $689.82. True Sentiment Bullish, delta 40-60 call 100% / put 0%, call $12,720 vs put $0. RSI 72.0.

Symbol
IDXX
Price
$689.82
Article bias (separate from True Sentiment)
bullish
Conviction
low
Published
2026-11-19 10:32:00 ET
Author
DeltaNeutral staff

TRUE SENTIMENT ANALYSIS (DELTA 40-60 OPTIONS)

True Sentiment Analysis (Delta 40-60 Options)

Options flow sentiment is Bullish. Call dollar volume 12,720.00 vs put 0.00 — 100.00% call share, 0 puts. Total directional options analyzed: 2 (filter ratio 0.30%). Pure conviction suggests near-term upside expectations. Divergence: technicals show overbought RSI with no clear direction per spread engine, yet sentiment is fully call-biased.

Note: Options flow shows 100.00% call dollar volume at Delta 40-60 filter.

Key Statistics: IDXX

$689.82 -1.53%
52-Week Range
$500.61 - $769.98
Market Cap
$54.35B
P/E (TTM)
46.30
PEG Ratio
N/A
Beta
1.22
Next Earnings
N/A
Avg Volume
$354,354
Dividend Yield
0.00%

Fundamental Snapshot

Valuation

P/E (trailing)46.30
EPS (trailing 12 mo)$14.91
Market cap$54.35B
Shares outstanding78.8M

Dividend

Dividend yield0.00%

Risk & range

Beta1.22
52-week low$500.61
52-week high$769.98
Historical volatility64.5%

Ownership & trading

Institutional ownership68.1%
Average daily volume0.7M sh

Reported figures; no analyst estimates.


📈 Analysis

News Headlines & Context

The following items reflect general knowledge context for IDEXX Laboratories (IDXX) and are separated from the data-driven analysis below:

  • IDXX reported steady demand in veterinary diagnostics through late 2026, with companion animal testing volumes remaining resilient despite macro pressure.
  • Recent sector headlines highlighted supply chain normalization for diagnostic reagents, a potential margin tailwind for IDXX.
  • No confirmed near-term earnings date was flagged in general coverage, but fiscal year-end is listed as 2025-12-01 in fundamentals, with potential FY reporting cues in early 2027.
  • Broader healthcare innovation news included expanded pet insurance adoption, a long-term demand catalyst for IDXX services.
  • Context: Bullish options flow in the embedded data contrasts with elevated RSI; news of stable end-markets may support the options conviction, but technicals show extended conditions.

Fundamental Analysis

Based strictly on the provided FUNDAMENTALS data:

  • Trailing P/E is 46.30 and trailing EPS is 14.91; valuation is premium versus typical healthcare peers, with no PEG ratio (null) available for growth-adjustment context.
  • Market cap is 54,348,158,520.00 with shares outstanding of 78,786,000.00 and beta of 1.22 (above 1.0, indicating elevated market sensitivity).
  • Dividend yield is 0.00 with no dividend rate or ex-date, so no income component.
  • Institutional ownership is 68.11%, reflecting moderate institutional sponsorship.
  • 52-week high is 769.98 and low is 500.61; current price near 700.54 sits in upper-middle of annual range.
  • Revenue growth, margins (gross/operating/net), ROE, debt/equity, and free cash flow are null in data — fundamental strength cannot be quantified beyond EPS and P/E.
  • Analyst consensus and target mean price are null; no street anchor exists in data.
  • Fundamentals (premium P/E, stable institutions) diverge from technicals showing RSI 72.03 (overbought) and bullish options delta flow.

Current Market Position

Current price from indicators is 700.54 as of 2026-11-18 close. Recent daily history shows close of 700.54 on 2026-11-18 after intraday range of 683.72 to 704.85. Minute bars for 2026-11-18 to 2026-11-19 10:05 show opening 684.64, peak 696.75 early, then drift to 689.82 by last bar with lows at 687.35. Intraday momentum is softening from 694.10 (09:30) to 689.82 (10:05) with volume declining from 8,339 to 4,977 in final bar.

Resistance
$713.74
Support
$683.72
20D SMA
$647.25
Bollinger Upper
$771.00
50D SMA
$572.87

Technical Analysis

Technical Indicators

RSI (14)
72.03
MACD
40.42 / 32.34
50-day SMA
$572.87
20-day SMA
$647.25
5-day SMA
$699.37
ATR (14)
32.72

SMA alignment: 5-day (699.37) > 20-day (647.25) > 50-day (572.87) — bullish stack with no bearish cross. RSI 72.03 signals overbought momentum. MACD histogram 8.08 positive (40.42 minus 32.34) confirms bullish momentum. Bollinger Bands: middle 647.25, upper 771.00, lower 523.50 — price above middle, near upper third. 30-day range high 713.74, low 506.12; current 700.54 is 94.30% up the range.

True Sentiment Analysis (Delta 40-60 Options)

Options flow sentiment is Bullish. Call dollar volume 12,720.00 vs put 0.00 — 100.00% call share, 0 puts. Total directional options analyzed: 2 (filter ratio 0.30%). Pure conviction suggests near-term upside expectations. Divergence: technicals show overbought RSI with no clear direction per spread engine, yet sentiment is fully call-biased.

Note: Options flow shows 100.00% call dollar volume at Delta 40-60 filter.

Key Price Levels (Observational Only)

Daily Low 11-18
$683.72
30D High
$713.74
5D SMA
$699.37
Bollinger Upper
$771.00

Interactive charts load with JavaScript. This text is the crawlable summary.